Steris PLC (NYSE:STE) VP John Adam Zangerle Sells 2,000 Shares

Steris PLC (NYSE:STE) VP John Adam Zangerle sold 2,000 shares of the firm’s stock in a transaction that occurred on Monday, September 14th. The shares were sold at an average price of $167.00, for a total transaction of $334,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Shares of NYSE:STE opened at $170.77 on Wednesday. The company’s fifty day moving average price is $158.29 and its 200 day moving average price is $152.08. Steris PLC has a 12 month low of $105.69 and a 12 month high of $170.71. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.29 and a quick ratio of 1.71. The firm has a market capitalization of $14.43 billion, a P/E ratio of 35.27 and a beta of 0.71.

Steris (NYSE:STE) last announced its quarterly earnings results on Monday, August 3rd. The medical equipment provider reported $1.31 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.98 by $0.33. Steris had a net margin of 13.69% and a return on equity of 16.24%. The firm had revenue of $668.90 million for the quarter, compared to analyst estimates of $643.38 million. During the same period last year, the business earned $1.23 EPS. Steris’s revenue for the quarter was down 4.0% compared to the same quarter last year. On average, sell-side analysts anticipate that Steris PLC will post 5.62 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 24th. Shareholders of record on Thursday, August 27th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Wednesday, August 26th. This is a positive change from Steris’s previous quarterly dividend of $0.37. This represents a $1.60 dividend on an annualized basis and a yield of 0.94%. Steris’s payout ratio is currently 28.37%.

STE has been the subject of several recent research reports. Needham & Company LLC initiated coverage on shares of Steris in a research report on Monday, August 3rd. They issued a “hold” rating for the company. Zacks Investment Research cut shares of Steris from a “hold” rating to a “sell” rating and set a $158.00 price target for the company. in a research report on Tuesday, July 14th. Finally, Robert W. Baird initiated coverage on shares of Steris in a research report on Tuesday, September 1st. They issued an “outperform” rating and a $175.00 price target for the company. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $167.67.

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. WCM Investment Management LLC increased its stake in Steris by 24.1% in the second quarter. WCM Investment Management LLC now owns 6,301,045 shares of the medical equipment provider’s stock valued at $966,832,000 after purchasing an additional 1,221,720 shares during the period. State Street Corp increased its stake in Steris by 2.3% in the first quarter. State Street Corp now owns 3,671,585 shares of the medical equipment provider’s stock valued at $513,916,000 after purchasing an additional 83,765 shares during the period. Massachusetts Financial Services Co. MA increased its stake in Steris by 4.1% in the first quarter. Massachusetts Financial Services Co. MA now owns 2,031,164 shares of the medical equipment provider’s stock valued at $284,303,000 after purchasing an additional 80,667 shares during the period. William Blair Investment Management LLC increased its stake in Steris by 14.7% in the first quarter. William Blair Investment Management LLC now owns 1,225,732 shares of the medical equipment provider’s stock valued at $171,566,000 after purchasing an additional 157,035 shares during the period. Finally, Invesco Ltd. increased its stake in Steris by 10.4% in the first quarter. Invesco Ltd. now owns 1,198,477 shares of the medical equipment provider’s stock valued at $167,751,000 after purchasing an additional 112,798 shares during the period. Institutional investors own 89.97% of the company’s stock.

About Steris

STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.

Featured Story: What sectors are represented in the Nikkei Index?

Insider Buying and Selling by Quarter for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.